I think we can gap up quickThe otc doesn't really have good pharma companies. All the good pharma stocks are trading on the nasdaq. The ones on the otc are mostly pump and dumps; Billion outstanding shares while pumping on twitter with zero clinical trials or progress. When Americans find out there's a legit undervalued company trading on the otc, they might be all over this thing (assuming good data ofcourse). We can sit here and talk about market valuation and fair value all we want, but hype is a total different ball game. If enough people buy in, this thing can gap up quick. I really feel like we can hit that 500M - 1B market much sooner. Having covid around is a blessing for this company.